IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent-Reference-Cited by-同舟云学术

IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent

Published:2019-08 Issue: Volume:102 Page:133-141
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Stremska Marta E.,Dai Chao,Venkatadri Rajkumar,Wang Hongyang,Sabapathy Vikram,Kumar Gaurav,Jose Sheethal,Mohammad Saleh,Sung Sun-sang J.,Fu Shu Man,Sharma Rahul

Funder

National Institute of Diabetes and Kidney Diseases, R01

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Lupus Research Alliance

National Institute of Diabetes and Kidney Diseases

National Institute of Allergy and Infectious Diseases

UVA AstraZeneca Research Alliance

UVA School of Medicine LaunchPad Diabetes Fund

UVA

University of Virginia Cancer Center National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Systemic lupus erythematosus;Tsokos;N. Engl. J. Med.,2011

2. Developments in the clinical understanding of lupus;Crow;Arthritis Res. Ther.,2009

3. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients;Cervera;Medicine,2003

4. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995;Ward;Arch. Intern. Med.,2000

5. New therapeutics in systemic lupus erythematosus;Paz;Curr. Opin. Rheumatol.,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of systemic lupus erythematosus (SLE);Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells;The Journal of Immunology;2024-03-22

3. Niche-specific control of tissue function by regulatory T cells—Current challenges and perspectives for targeting metabolic disease;Cell Metabolism;2024-02

4. Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes;Pharmacological Reviews;2023-12-13

5. Research advances on targeted-Treg therapies on immune-mediated kidney diseases;Autoimmunity Reviews;2023-02